Remove tag optimisation
article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

Yet apart from radio-frequency identification (RFID) tags and QR codes, adoption at scale has proved challenging overall, the report stated. Types of technologies such as wirelessly connected tags (active and passive) and sensors were also specified. This is driving the adoption of item-level smart labelling , the report noted.

article thumbnail

Novel nanofiltration method for microbial biosurfactant downstream processing

European Pharmaceutical Review

This indicates that scalable fermentations and downstream processes are sub-optimised. Methods of the microbial biosurfactant study The first stage of the downstream method combined TAG selective removal from glycolipids. However, the price of the cheapest mBs is ten-fold in cost compared to chemical surfactants.

66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). According to Kahn, this results in a need for improved and optimised commercialisation solutions across the industry.

article thumbnail

Cartherics grants licence for CTH-004 to Shunxi

Pharmaceutical Technology

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP.

52
article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. Sickle cell disease is an inherited blood disorder that is caused by mutations in the HBB gene, which codes for the oxygen-carrying protein haemoglobin in red blood cells.

FDA 59
article thumbnail

Q&A: A decade on, what’s next for CAR-T therapies?

Pharmaceutical Technology

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. Currently, all approved CAR-T therapies are autologous, where T cells taken from patients are modified and then re-infused. Topic sponsors are not involved in the creation of editorial content.

FDA 59
article thumbnail

What is modular content and why do pharma marketers need it NOW?

pharmaphorum

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. As the leading creative production partner to brands and agencies, Tag offers a complementary skillset to in-house teams and advertising agencies to bring to life, extend and deploy creative ideas.